REG - Haleon PLC - Director/PDMR Shareholding

HALEONAnnouncement

22/11/2024 16:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241122:nRSV3910Na&default-theme=true

RNS Number : 3910N  Haleon PLC  22 November 2024

 

Haleon plc: Director/PDMR Shareholding

 

22 November 2024: Haleon plc (the "Company" or "Haleon") (LSE/NYSE:HLN) today
announces notification and public disclosure in accordance with the
requirements of The UK Market Abuse Regulation of Transactions by a Person
Discharging Managerial Responsibilities ("PDMR").

 

On 21 November 2024, Dawn Allen, Chief Financial Officer, received the vesting
of an award of Haleon Ordinary Shares under the Haleon Share Value Plan. The
award was granted as part of her remuneration arrangements upon joining
Haleon, to compensate for forfeited incentives from her previous employment.

 

Immediately following vesting 74,678.928393 Ordinary Shares were sold to cover
tax obligations at a price of £3.718 per share, with the remaining
83,974.071607 Ordinary Shares retained subject to a two-year holding period.

 

The award is subject to malus and clawback provisions.

 

Further details are set out in the below notification, made in accordance with
the requirements of The UK Market Abuse Regulations.

 

 

       1                        Details of the person discharging managerial responsibilities / person closely

                        associated

       a)                       Name                                                             Dawn Allen

       2                        Reason for the notification

       a)                       Position/status                                                  Chief Financial Officer

       b)                       Initial notification /Amendment                                  Initial Notification

       3                        Details of the issuer, emission allowance market participant, auction

                        platform, auctioneer or auction monitor

       a)                       Name                                                             Haleon plc

       b)                       LEI                                                              549300PSB3WWEODCUP19

       4                        Details of the transaction(s): section to be repeated for (i) each type of

                        instrument; (ii) each type of transaction; (iii) each date; and (iv) each
                                place where transactions have been conducted
       a)                       Description of the financial instrument, type of instrument      Ordinary Shares of £0.01 each

                                Identification code                                              GB00BMX86B70

       b)                       Nature of the transaction                                        Acquisition of Ordinary Shares in respect of the Haleon plc Share Value Plan

                                                                (Buyout award).

       c)                       Price(s) and volume(s)

                                                                                                                                     Price(s)          Volume(s)
                                                                                                                                     Nil               158,653

       d)                       Aggregated information

                                - Aggregated volume                                              N/A

                                - Price

       e)                       Date of the transaction                                          21 November 2024

       f)                       Place of the transaction                                         Outside a trading venue

 4                              Details of the transaction(s): section to be repeated for (i) each type of

                              instrument; (ii) each type of transaction; (iii) each date; and (iv) each
                                place where transactions have been conducted
 a)                             Description of the financial instrument, type of instrument      Ordinary Shares of £0.01 each

       Identification code      GB00BMX86B70

 b)                             Nature of the transaction                                        Automatic disposal of Ordinary Shares resulting from the Haleon plc Share

                                                                Value Plan (Buyout award) vesting to cover tax liabilities.

 c)                             Price(s) and volume(s)

                                                                                                                   Price(s)          Volume(s)
                                                                                                                   £3.718            74,678.928393

 d)                             Aggregated information

       - Aggregated volume      N/A

       - Price

 e)                             Date of the transaction                                          21 November 2024

 f)                             Place of the transaction                                         London Stock Exchange (XLON) 

 

 

Amanda Mellor

Company Secretary

 

About Haleon

Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose
to deliver better everyday health with humanity. Haleon's product portfolio
spans five major categories - Oral Health, Pain Relief, Respiratory Health,
Digestive Health and Other, and Vitamins, Minerals and Supplements (VMS). Its
long-standing brands - such as Advil, Sensodyne, Panadol, Voltaren, Theraflu,
Otrivin, Polident, parodontax and Centrum - are built on trusted science,
innovation and deep human understanding.

 

For more information, please visit www.haleon.com (http://www.haleon.com/)
.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHBUBDBBXDDGSD